analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Here are complete model answers for all questions in the paper:

ASMC-ABVMU Ophthalmology Exam - Model Answers


PART A - Long Question (20 Marks)

Case: 60-year-old female, gradual bilateral vision loss over 3 years. IOP: RE 28 mmHg, LE 34 mmHg; circumciliary congestion in LE.

(a) Differential Diagnosis (2 marks)

The two most likely diagnoses are:
  1. Primary Open Angle Glaucoma (POAG) - bilateral, asymmetric, elevated IOP (28 & 34 mmHg), gradual progressive vision loss
  2. Primary Angle Closure Glaucoma (PACG) - especially for the LE which has circumciliary congestion, very high IOP (34 mmHg), suggesting acute or subacute angle closure
The right eye presents more as POAG (no congestion, moderately elevated IOP), while the left eye presentation with circumciliary congestion favors PACG or acute exacerbation.

(b) Define Glaucoma and List Risk Factors (3 marks)

Definition: Glaucoma is a chronic, progressive optic neuropathy characterized by:
  • Characteristic structural damage to the optic nerve head (cupping)
  • Corresponding visual field defects
  • In most cases, raised IOP (though IOP may not always be elevated in normal-tension glaucoma)
Risk Factors for Glaucoma:
Risk FactorDetail
Raised IOPMost important modifiable risk factor; >21 mmHg
AgeRisk increases after age 40; significantly higher >60
Family historyFirst-degree relative increases risk 4-9x
RaceAfrican-Americans: higher risk of POAG; Asians: higher risk of PACG
MyopiaHigh myopia predisposes to POAG
HypermetropiaShallow AC - predisposes to angle closure
Thin central corneal thickness (CCT)<555 µm - risk factor for POAG
Diabetes mellitusIncreased risk of POAG
Systemic hypertensionAssociated with vascular optic neuropathy
Corticosteroid useTopical or systemic steroids can raise IOP
Previous ocular traumaSecondary glaucoma

(c) Classify Glaucoma (4 marks)

A. By Mechanism of IOP Elevation
1. Primary Glaucoma (no identifiable cause)
  • Primary Open Angle Glaucoma (POAG)
    • Most common type worldwide
    • Angle is anatomically open
    • Trabecular meshwork dysfunction - aqueous outflow resistance increased
    • Chronic, asymptomatic, bilateral
    • Also: Normal Tension Glaucoma (NTG) - IOP consistently ≤21 mmHg
  • Primary Angle Closure Glaucoma (PACG)
    • Anatomical obstruction at angle by iris
    • Subtypes:
      • Acute PACG (symptomatic: pain, redness, halos, nausea)
      • Subacute (intermittent)
      • Chronic PACG
      • Primary angle closure suspect (PACS) - narrow angle, no damage
      • Primary angle closure (PAC) - narrow angle, raised IOP, no disc damage
2. Secondary Glaucoma (identifiable cause)
  • Open angle: Pseudoexfoliation glaucoma, pigmentary glaucoma, uveitic glaucoma, traumatic, steroid-induced
  • Angle closure: Neovascular glaucoma (rubeosis iridis), phacolytic, lens-induced, iris bombe in uveitis
3. Developmental / Congenital Glaucoma
  • Primary congenital glaucoma (trabeculodysgenesis)
  • Sturge-Weber syndrome, Axenfeld-Rieger syndrome

B. By Age of Onset
  • Congenital (birth - 3 years): Buphthalmos
  • Infantile (3 months - 3 years)
  • Juvenile (3 - 35 years)
  • Adult (>35 years)

(d) Disc Changes and Visual Field Changes (6 marks)

Optic Disc Changes in Glaucoma

Normal disc: Cup-to-disc (C:D) ratio ≤0.4, pink neuroretinal rim (NRR) with ISNT rule (Inferior > Superior > Nasal > Temporal rim width)
Glaucomatous changes (in order of progression):
  1. Increased C:D ratio:
    • C:D >0.6 is suspicious
    • C:D >0.7 or asymmetry between eyes >0.2 is significant
    • Vertical elongation of cup (vertical C:D > horizontal)
  2. Neuroretinal rim thinning / notching:
    • Inferior pole first → then superior → then nasal/temporal
    • Notching: focal loss of NRR, most commonly inferotemporal or superotemporal
  3. Disc haemorrhages (Drance haemorrhages):
    • Splinter/flame-shaped haemorrhages at disc margin
    • Early marker, more common in NTG
    • Predict future field loss
  4. RNFL (Retinal Nerve Fiber Layer) defects:
    • Wedge-shaped RNFL defects visible on red-free photography
    • Superotemporal and inferotemporal most common
  5. Bayoneting of vessels:
    • Blood vessels appear to double-back at disc margin due to deep excavation
  6. Bean-pot cupping:
    • Severe stage - cup extends under disc rim (overhanging edges)
  7. Nasal shift of vessels / Nasalization:
    • Central retinal vessels shift nasally
  8. Peripapillary atrophy (PPA):
    • Beta zone (direct surrounds disc) more significant than alpha zone

Visual Field Changes in Glaucoma (Sequence)

StageField Defect
EarlyEnlargement of blind spot; isopter contraction
Early-moderateBjerrum's scotoma / arcuate scotoma (follows RNFL arc from blind spot, between 10-20° from fixation)
ModerateSeidel scotoma (comma-shaped extension from blind spot)
Moderate-advancedArcuate or ring scotoma (double arcuate = annular scotoma)
AdvancedNasal step (Ronne's nasal step) - asymmetric field loss at horizontal midline nasally
LateAltitudinal defect (half the field - superior or inferior)
End-stageTunnel vision (only central island remains) → eventual loss of central vision

(e) Investigations and Management of POAG (5 marks)

Investigations

To confirm diagnosis:
  1. Tonometry - Goldmann applanation tonometry (gold standard for IOP)
  2. Gonioscopy - to assess angle; confirms open angle in POAG
  3. Optic disc assessment - Slit lamp with +90D lens / direct ophthalmoscope; fundus photography
  4. Visual fields - Humphrey automated perimetry (24-2 or 30-2 program); Frequency Doubling Technology (FDT)
  5. OCT (Optical Coherence Tomography) - RNFL thickness, ganglion cell complex analysis; detects structural loss before field loss
  6. HRT (Heidelberg Retinal Tomograph) - 3D disc topography
Other: 7. Central Corneal Thickness (CCT) - thin CCT underestimates IOP; adjust target IOP accordingly 8. Diurnal IOP curve - 4-hourly IOP over a day to detect peak IOP 9. Blood pressure measurement - calculate ocular perfusion pressure 10. Systemic evaluation - rule out secondary causes (blood sugar, thyroid)

Management of POAG

Goal: Reduce IOP to a "target pressure" at which optic nerve damage progression is halted or slowed.
Step 1 - Medical Management (First-line)
Drug ClassDrugMechanismDose
Prostaglandin analogues (first choice)Latanoprost, Travoprost, BimatoprostIncrease uveoscleral outflowOnce daily at night
Beta-blockersTimolol 0.5%Reduce aqueous productionBD
Alpha-2 agonistsBrimonidine 0.2%Reduce production + increase outflowBD/TDS
Carbonic anhydrase inhibitors (topical)Dorzolamide, BrinzolamideReduce aqueous productionBD/TDS
CAI (systemic)Acetazolamide 250mgReduce productionTDS-QID (short term)
Miotic (rarely)Pilocarpine 2-4%Increase trabecular outflowQID
Combination drops (e.g., Cosopt - Timolol + Dorzolamide; Combigan - Timolol + Brimonidine) improve compliance.
Step 2 - Laser Treatment
  • Selective Laser Trabeculoplasty (SLT): Laser applied to trabecular meshwork; improves drainage; can be used as primary or adjunct therapy; repeatable
  • Argon Laser Trabeculoplasty (ALT): Similar but less repeatable
Step 3 - Surgical Management
  • Trabeculectomy (Filtration surgery): Creates a new drainage pathway from AC to subconjunctival space (filtering bleb). Antifibrotics (Mitomycin C, 5-FU) enhance success. Gold standard surgical option.
  • Tube/Shunt surgery (Glaucoma Drainage Device - GDD): Ahmed, Baerveldt, Molteno implants - for cases where trabeculectomy has failed or is likely to fail
  • Minimally Invasive Glaucoma Surgery (MIGS): iStent, Hydrus - for mild-moderate POAG combined with cataract surgery
  • Cycloablation: Diode laser cycloablation - for refractory end-stage glaucoma
Follow-up: Regular monitoring of IOP, RNFL on OCT, and visual fields every 6-12 months to assess progression.


PART A - Short Notes (5 marks each)


1. Types of Intraocular Lens (IOL)

An IOL is an artificial lens implanted in the eye, most commonly after cataract extraction, to replace the natural crystalline lens.
Classification:
A. By Position in Eye:
TypePositionDetails
Posterior chamber IOL (PCIOL)In the capsular bag (most common)Placed behind iris, in the capsular bag after ECCE/phaco
Anterior chamber IOL (ACIOL)Anterior to irisUsed when posterior capsule is ruptured; less preferred
Iris-fixated IOLClipped to irisE.g., Artisan lens
Sulcus IOLCiliary sulcusWhen capsular bag is inadequate
B. By Material:
  • PMMA (Polymethylmethacrylate): Rigid, non-foldable; older lenses; requires larger incision (~6mm)
  • Acrylic (hydrophobic/hydrophilic): Most commonly used today; foldable; injected through 2.2-2.8mm incision
  • Silicone: Foldable; not suitable if silicone oil is likely to be used
  • Collamer (HEMA): Used in phakic IOLs (e.g., ICL - Implantable Collamer Lens)
C. By Optical Design:
TypeFeatureIndication
MonofocalSingle focal point (distance)Standard; patient needs reading glasses
Multifocal (MIOL)Multiple focal points (distance + near)Reduced spectacle dependence; risk of halos/glare
Extended Depth of Focus (EDOF)Elongated focal rangeBetter intermediate vision; fewer dysphotopsias
Toric IOLCorrects astigmatismPatients with corneal astigmatism ≥1.5D
Accommodating IOLShifts position to mimic accommodationLimited effectiveness
D. Special Types:
  • Phakic IOL: Implanted with the natural lens still in situ; for refractive correction of high myopia (e.g., Visian ICL, Artisan)
  • Scleral-fixated IOL: Fixated to sclera with prolene sutures when no capsular support exists
  • Blue-light filtering IOL: Contains yellow chromophore to filter blue light and protect macula
Power Calculation: A-scan biometry + IOL Master; formulae: SRK/T, Hoffer Q, Holladay, Barrett Universal II

2. Superior Orbital Fissure - Draw and Structures Passing Through It

Superior Orbital Fissure (SOF): A cleft between the greater and lesser wings of the sphenoid bone, connecting the middle cranial fossa to the orbit.
Shape: Comma-shaped / laterally wider, medially narrowed
Structures passing through (Divided by Annulus of Zinn / Common Tendinous Ring):
WITHIN the Annulus of Zinn (inside the muscle cone):
  • Oculomotor nerve (CN III) - superior & inferior divisions
  • Nasociliary nerve (branch of CN V1)
  • Abducens nerve (CN VI)
  • Mnemonic: "LOAN" - Lacrimal, Oculomotor, Abducens, Nasociliary (inside ring)
OUTSIDE the Annulus of Zinn (outside muscle cone):
  • Lacrimal nerve (branch of CN V1)
  • Frontal nerve (branch of CN V1)
  • Trochlear nerve (CN IV)
  • Superior ophthalmic vein
  • Inferior ophthalmic vein (joins/passes near)
  • Sympathetic fibers (from plexus)
Mnemonic for structures outside ring: "Lazy French Tarts Sit Naked In Anticipation" - Lacrimal, Frontal, Trochlear, Superior ophthalmic vein
Summary Table:
StructureDivision of CNLocation
CN III superior divisionOculomotorInside ring
CN III inferior divisionOculomotorInside ring
CN VI (Abducens)-Inside ring
Nasociliary nerveCN V1Inside ring
CN IV (Trochlear)-Outside ring
Lacrimal nerveCN V1Outside ring
Frontal nerveCN V1Outside ring
Superior ophthalmic vein-Outside ring
Note: The optic nerve (CN II) passes through the Optic Canal, NOT the superior orbital fissure.
Clinical: SOF syndrome (Rochon-Duvigneaud syndrome) - involvement of CN III, IV, V1, VI causing ophthalmoplegia + V1 sensory loss + ptosis + proptosis (due to tumour, thrombosis, fracture, aneurysm in region).

3. Hypermetropia - Definition, Signs, Symptoms & Management

Definition: A refractive error in which parallel rays of light coming from infinity are focused behind the retina, when accommodation is relaxed. The eyeball is too short (axial hypermetropia) or the refracting power of the eye is too weak (refractive hypermetropia).
Types:
  • Axial: Short AP diameter (most common)
  • Refractive: Reduced corneal/lens curvature, or reduced refractive index
  • Positional: Posterior displacement of lens
Degrees: Low (<+2D), Moderate (+2 to +5D), High (>+5D)
Classification by Accommodation:
  • Latent: Corrected by inherent tone of ciliary muscle; not detected without cycloplegic refraction
  • Manifest:
    • Facultative: Can be corrected by accommodation
    • Absolute: Cannot be corrected by accommodation (exhausted)
  • Total: Latent + Manifest (measured under cycloplegia)
Signs:
  • Small eyeball / short axial length on A-scan
  • Small corneal diameter
  • Shallow anterior chamber
  • Fundoscopy: Small disc, crowded disc appearance (pseudopapilledema), reduced cup-to-disc ratio
  • Cross-eyes in children (accommodative esotropia)
Symptoms:
  • Asthenopia (eyestrain, headache - frontal/brow ache after near work)
  • Blurring of near vision (absolute hypermetropia)
  • Blurring of distance vision (high degrees)
  • In children: Crossed eyes (accommodative convergent squint)
  • Predisposition to acute angle closure glaucoma (shallow AC)
  • Reading fatigue, difficulty concentrating
Management:
  1. Optical correction:
    • Spectacles with convex (+) lenses (full correction under cycloplegia in children; in adults, prescribe the maximum plus accepted)
    • Contact lenses (daily soft lenses or toric for astigmatism)
  2. Refractive surgery:
    • LASIK / LASEK / PRK: For low to moderate hypermetropia (<+4-5D); treats up to +6D in some centers
    • SMILE: Available for myopia primarily; not for hypermetropia
    • Phakic IOL (ICL): For high hypermetropia not amenable to corneal surgery
    • Clear Lens Extraction (Refractive Lens Exchange): For high hypermetropia in older patients; with multifocal/EDOF IOL
  3. Treat amblyopia (in children): Patching of the better eye; penalization

4. Viral Keratitis - Signs, Symptoms & Management

The most common cause of viral keratitis is Herpes Simplex Virus (HSV-1). Other causes include Herpes Zoster Ophthalmicus (HZV), Adenovirus, Acanthamoeba (not viral but often grouped).
A. Herpes Simplex Keratitis (HSK)
Subtypes:
TypeFeatures
Epithelial keratitisMost common; dendritic ulcer (branching with terminal bulbs); rose bengal/fluorescein stains
Geographic (amoeboid) ulcerLarge irregular epithelial ulcer (usually post-steroid use)
Stromal keratitisInterstitial keratitis; disc keratitis; necrotizing keratitis
Endothelial keratitisKeratouveitis; linear endotheliitis
Metaherpetic keratitisHealed/scarred; not active virus - trophic ulcer
Symptoms:
  • Foreign body sensation, photophobia, lacrimation
  • Blurred vision (if involving visual axis)
  • Pain (usually mild in epithelial type; more severe in stromal/uveitis type)
  • Herpetic vesicles on lid/perioral skin (in primary infection)
  • Reduced corneal sensation (hypoesthesia - hallmark of repeated HSV infection)
Signs:
  • Dendritic ulcer: Branching linear lesion with terminal bulbs - pathognomonic of HSV epithelial keratitis
  • Staining with rose bengal (stains devitalized cells) and fluorescein
  • Reduced corneal sensation (cotton wisp test)
  • Stromal haze / ghost vessels / lipid deposits (in chronic stromal keratitis)
  • Corneal vascularization in chronic disease
  • Disciform oedema (Wessely immune ring) in stromal disease
  • Iritis/uveitis with keratic precipitates (KPs) in keratouveitis
Management:
StageTreatment
Epithelial HSKTopical antiviral: Acyclovir 3% ointment 5x/day for 14 days OR Ganciclovir 0.15% gel 5x/day; Debridement; NO steroids
Stromal HSKTopical steroids (Prednisolone) + topical antiviral (cover); oral acyclovir 400mg 3-5x/day
Prophylaxis for recurrenceOral acyclovir 400mg BD or valacyclovir 500mg OD for 1 year (HEDS trial)
KeratoplastyFor severe corneal scarring with reduced vision - penetrating keratoplasty
B. Herpes Zoster Ophthalmicus (HZO)
  • Reactivation of VZV in trigeminal nerve, ophthalmic division (V1)
  • Hutchinson's sign (vesicles on tip of nose = nasociliary branch involved = high risk of ocular involvement)
  • Keratitis: Pseudodendrites (mucus plaques - no terminal bulbs - different from HSV dendrites)
  • Treatment: Oral acyclovir 800mg 5x/day for 7-10 days within 72 hours; topical lubricants; steroids for stromal inflammation

5. Vernal Keratoconjunctivitis (VKC)

Pathophysiology

VKC is a chronic, recurrent, bilateral allergic conjunctivitis with both IgE-mediated (Type I hypersensitivity) and cell-mediated (Type IV) immune mechanisms playing important roles.
  • Mast cell degranulation releases histamine, tryptase, prostaglandins, leukotrienes
  • Eosinophils are recruited → release major basic protein (MBP) causing epithelial toxicity
  • Th2 lymphocytes release IL-4, IL-5, IL-13 (IgE class switching, eosinophil recruitment)
  • Giant papillae form due to fibroblast activation by TGF-β and substance P

Signs and Symptoms

Symptoms:
  • Intense itching (cardinal symptom)
  • Lacrimation, photophobia
  • Foreign body sensation, burning
  • Thick ropy/stringy mucoid discharge
  • Increased blinking
  • Seasonal exacerbation (late spring/summer)
Signs - Palpebral VKC (Upper tarsal plate):
  • Cobblestone papillae (<1mm): flat-topped polygonal papillae
  • Giant papillae (>1mm): formed when septa rupture
  • Whitish inflammatory infiltrates in severe disease
Signs - Limbal VKC (common in dark-skinned patients):
  • Gelatinous limbal papillae
  • Horner-Trantas dots: White chalky dots at limbus = eosinophil aggregates; pathognomonic of VKC
  • Maxwell-Lyons sign: Fine superficial keratitis
Corneal involvement:
  • Superior punctate epithelial erosions
  • Epithelial macroerosions (shield ulcer) - sterile; upper 1/3 of cornea
  • Plaques (white calcium deposits in shield ulcer)
  • Pseudogerontoxon: Lipid arc at limbus

Types of VKC

  1. Palpebral type: Upper tarsal plate involvement predominates
  2. Limbal type: Limbal involvement predominates (more common in Africans and Asians)
  3. Mixed type: Features of both

Management

ApproachDrug/Intervention
Mast cell stabilizers (first-line, chronic)Sodium cromoglicate 2%, Lodoxamide 0.1% (more potent)
Antihistamines (topical)Olopatadine, Ketotifen, Azelastine - dual action (antihistamine + mast cell stabilizer)
Steroids (short course for acute exacerbation)Fluorometholone, Loteprednol (safer); Prednisolone 1% (short courses only) - monitor IOP
Cyclosporine 0.05-1% (steroid-sparing)Immunomodulation; reduces papillary hypertrophy; for moderate-severe/steroid-dependent VKC
Tacrolimus 0.03% (alternative to cyclosporine)FK506; effective for severe/refractory VKC
Oral antihistaminesLoratadine (non-sedating); Diphenhydramine (sedating - useful for sleep)
Supratarsal steroid injectionTriamcinolone acetonide - for refractory palpebral VKC with giant papillae
Cold compressesSymptomatic relief
Avoidance of triggersSun, dust, pollen
SurgicalDebridement of plaques, excision of giant papillae (rarely needed)

6. Factors Responsible for Transparency of Cornea

The cornea is normally transparent, allowing 90% of light to pass through. Several structural and biochemical factors maintain this transparency:
1. Avascularity
  • Cornea has NO blood vessels; vascularization causes opacity
  • Nutrition via aqueous humor (anteriorly), tears, and diffusion from limbal vessels (periphery)
2. Absence of Myelination
  • Corneal nerves lose their myelin sheaths at the limbus (Dohlman)
  • Myelin is opaque; absence ensures transparency
3. Regular Arrangement of Collagen Fibrils (Maurice's Lattice Theory)
  • Collagen fibrils in the stroma are of uniform diameter (~25nm) and regularly spaced (spacing < half wavelength of visible light ~200nm)
  • Regular spacing leads to destructive interference of scattered light waves → no net scatter → transparency
  • Type I and V collagen fibrils maintained in regular array by proteoglycans (keratan sulphate and chondroitin sulphate-containing proteoglycans - lumican, mimecan, keratocan, decorin)
4. Relative Dehydration of Stroma (Deturgescence)
  • Stroma has a natural tendency to imbibe water (hydrophilic proteoglycans)
  • Maintained in a relatively dehydrated state (78% water) by two active pumping mechanisms:
    • Corneal endothelium (most important): Na+/K+-ATPase pump; bicarbonate pump; actively transports fluid from stroma into AC
    • Corneal epithelium: Barrier function preventing excess water entry from tears
  • Loss of endothelial function (Fuchs dystrophy, surgical trauma, endothelial cell count <500/mm²) → corneal oedema → clouding
5. Smooth Anterior Surface
  • Maintained by the pre-corneal tear film (mucin, aqueous, lipid layers)
  • Irregular surface (dry eye, scarring) → scattering → reduced clarity
6. Absence of Pigment
  • No melanin or other pigment in corneal layers (unlike iris/retina)
7. Uniform Epithelium
  • Epithelium must be smooth and intact; disruption causes scattering
8. Bowman's Layer and Descemet's Membrane
  • These acellular collagenous layers are also transparent by virtue of regular structure
Summary (Mnemonic - "CARDSAP"):
  • Collagen regular arrangement (Maurice's theory)
  • Avascularity
  • Relative dehydration (endothelial pump)
  • Deturgescence
  • Smooth tear film surface
  • Absence of pigment / myelination
  • Proteoglycans maintaining fibril spacing

Source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Edition; standard ophthalmic textbooks.
This is a shared conversation. Sign in to Orris to start your own chat.